Case series reports unusual dorsal hand-foot syndrome in patients undergoing docetaxel chemotherapy, suggesting supportive care's role in management.
Palmar–plantar erythrodysesthesia, also known as hand–foot syndrome (HFS), can occur with a variety of cytotoxic chemo drugs including fluoropyrimidines, cytarabine, liposomal doxorubicin and taxanes. It often presents as painful erythemas and desquamation of the skin involving the palms of the hands and the soles of the feet. Three cases are presented of patients who received multiagent chemotherapy regimens containing docetaxel that developed an atypical presentation of HFS on the dorsal aspect of the hands and feet. Dorsal HFS improved with supportive care or dose reduction.
No takes yet. Share an insight, caveat, or question.
Bhatti et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: